Navigation Links
Varian Medical Systems Schedules Investor Meeting at ASTRO in San Francisco
Date:8/11/2014

PALO ALTO, Calif., Aug. 11, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) will hold a meeting for investors on Tuesday, September 16, at the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Francisco.

Varian will host a meeting with management, beginning with breakfast at 7:30 a.m. and webcast presentations from 8:00 a.m. to 10:00 a.m. on Tuesday at the San Francisco Marriott Marquis, 780 Mission Street, in the Nob Hill meeting room.  Presentations by leading clinicians and Varian managers will focus on clinical needs in radiation oncology and how they are being addressed.

To RSVP for the meeting , click on: http://varian.investorroom.com/ASTRO , or contact Anne Rambo at (650) 424-5834, or by e-mail: anne.rambo@varian.com.  Please RSVP by Tuesday, September 9, 2014. 

The meeting and presentation will be webcast beginning at 8:00 a.m. Pacific Time.  To access the webcast, click on http://investors.varian.com/index.php?s=19&item=253.

To reserve a hotel room in San Francisco and to register for additional ASTRO seminars, please visit the ASTRO web site at www.astro.org or call (800) 541-6058.

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging.  The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of X-ray imaging components, including tubes and digital detectors, for use in medical, scientific, and industrial settings, as well as for security and non-destructive testing.  Varian Medical Systems employs approximately 6,700 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world.  For more information, visit http://www.varian.com or follow us on Twitter.

FOR INFORMATION CONTACT:
Spencer Sias, (650) 424-5782
Vice President, Corporate Communications
and Investor Relations
spencer.sias@varian.com


'/>"/>
SOURCE Varian Medical Systems
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems Announces Acquisition of Certain Assets of Transpire, Inc., a Specialized Developer of Radiation Simulation Software
2. Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland
3. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014
4. CIVCO to Showcase Protura and Varian Interface at AAPM 2014
5. Varian to Highlight Software that Augments Quality Assurance Processes in Radiation Oncology at the 2014 American Association of Physicists in Medicine (AAPM) Meeting
6. Varian Medical Systems Holds Developer Workshop for Researchers Working on Next Generation Technologies in Radiation Oncology
7. Yashoda Cancer Institute Commences Radiosurgery Treatments Using Varian Clinac Linear Accelerator
8. CRLX101 Meets Primary Endpoint in Phase 2 Clinical Trial in Relapsed Ovarian Cancer
9. Varian Medical Systems Publishes 2013 Annual Report on Investor Web Site
10. Varian Imaging Components President Robert Kluge Announces Plans to Retire; Varian CEO Dow Wilson Names Sunny Sanyal as Kluges Successor
11. Varian Medical Systems Schedules First Quarter FY2014 News Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Spain Glaucoma Surgery Devices Market Outlook to ... Surgery Devices Market Outlook to 2022", provides key market ... report provides value, in millions of US dollars, volume ... - Canaloplasty Micro Catheters and Glaucoma Drainage Devices. ... data for each of these market segements, and global ...
(Date:12/5/2016)...  Cornerstone Pharmaceuticals, Inc., a privately held, clinical-stage, ... Phase I trials evaluating its lead compound, CPI-613, ... of the American Society of Hematology (ASH) in ... two datasets show encouraging efficacy and safety results ... T-cell non-Hodgkin,s lymphoma (T-cell NHL), respectively, supporting the ...
(Date:12/5/2016)... , Dec. 5, 2016  Pennsylvania Physician General Dr. ... Alcohol Programs Gary Tennis today filled prescriptions ... Minnich,s Pharmacy in York to ... by Dr. Levine as a prescription to acquire naloxone ... "It,s important to remember that any Pennsylvanian can walk ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... ... until January 15, 2017 to apply for a 2016/2017 California Casualty Thomas R. ... . Qualifying schools can receive up to $3,000. , The grant ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... in research and development, largely due to its potential for revolutionizing human disease ... (hMSCs) and human induced pluripotent stem cells (hiPSCs). , Both platforms have ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... released the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has ... the world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every ...
(Date:12/6/2016)... ... 2016 , ... TopConsumerReviews.com recently gave a best-in-class 5 star rating to SpinLife, ... freedom to people who need help getting around. For some, advancing age has led ... of rehabilitation after an illness or accident. There is a wide variety of scooters, ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
Breaking Medicine News(10 mins):